Digital China Health Technologies chipped into the third tranche of a round featuring fellow corporates BGI Genomics and Healthlink that now tops $30m.
UK-based clinical genomics software developer Congenica has increased a series B round featuring Digital China Health (DC Health) Technologies, a corporate venturing vehicle for IT services group Digital China Holdings, to £23.3m ($30.1m).
Parkwalk Advisors, the fund management division of commercialisation firm IP Group, led a $17.1m extension to the round that included DC Health and unnamed strategic and existing investors.
Congenica raised $10m in a first close led by a Cambridge Innovation Capital (CIC), the patient capital fund affiliated…
